The New Jefferson Vascular Center Offers Multi-disciplinary Approach to Treating Vascular Disease Under One Roof
(Published 2-24-2010) The new Jefferson Vascular Center (JVC) at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof. Millions of adults in the United States develop thrombotic disorders every year so having a state-of-the-art center with all the clinical and diagnostic tools in one localized area provides the best possible treatment options for patients.

Jefferson Enrolls First U.S. Patient in STABLE Aortic Dissection Trial
(Published: 2-11-2008) – Cook Medical today announced enrollment of the first U.S. patient in the STABLE global clinical trial designed to evaluate the Cook Zenith® Dissection Endovascular System for the treatment of Type B thoracic aortic dissections. This is the first device designed specifically to treat aortic dissections, the condition that took the life of actor John Ritter. The technologically advanced device is the first-of-its-kind worldwide and was designed to treat the unique morphology of this disease, a major cause of mortality worldwide.

Jefferson Vascular Surgeon Creating a New Blood Vessel Bypass 
(Published 2-13-2006) Vascular surgeons at Thomas Jefferson University in Philadelphia are developing a novel vascular bypass graft that has the potential of helping thousands of patients, including those suffering with atherosclerosis, a common condition known as “hardening of the arteries.”